Competitive Landscape of COVID-19 Therapies

Objective :

COVID-19 developmental pipeline assessment, identifying key competitors, and evaluating emerging therapies in the domain.

Problem Statement:

A mid-sized EU-based firm involved DelveInsight in assessing the developmental pipeline of COVID-19 to assess the competitors across the clinical development pipeline. They wished to identify and evaluate emerging therapies, key competitors and assess the landscape based on the mechanism of action, route of administration, and others of the emerging candidates.

Our Methodology:

Therapeutic R&D Developmental Pipeline Assessment
Assessment of the Drugs
Key Pharmaceuticals Portfolio Assessment
Strategic Planning Assistance

Results:

Detailed profiling of Active Products in the Pipeline
Landscape analysis of various Mechanisms of Action and Routes of Administration
Matrix Analysis positioned the top 10 Companies researched.
The client can appraise all the top companies that can serve as a potential competition

Related case Studies

Pipeline Assessment Partner Identification Competitive Benchmarking Go-To-Market Strategy Competitive Intelligence Product Assessment Market Size & Forecast Assessment

Sample Visuals

Get Visuals

Related Insights

Pipeline Assessment

A medium pharmaceutical client based in the United States with capabilities in cancer immunotherapy domain involved DelveInsight to analyze current pipeline activity of T-Cell Receptor (TCR) products for cancer treatment. [...]

View Case

Partner Identification

A medium pharmaceutical client based in the US, with innovative formulations to treat Head and Neck Cancer, involved DelveInsight to identify a co-development partner, for the US and European region. [...]

View Case

Competitive Benchmarking

A large pharmaceutical client based in Europe involved DelveInsight to identify patient advocacy strategies of companies operating in the Pharma sector of the European Union, to benchmark their efforts against their competitors. [...]

View Case